Andrew N. Cornforth

Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma

Robert O. Dillman, Christopher Duma, Robin Ellis et al. · Journal of Immunotherapy · 2009 · 107 citations

Cell Therapy, Surgical Oncology, Immunology +23

FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells

Andrew N. Cornforth, Jennifer S. Davis, Elham Khanifar et al. · Oncogene · 2008 · 77 citations

Developmental Biology, Signal Transduction, Signaling Pathway +12

Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy

Robert O. Dillman, Andrew N. Cornforth, Carol DePriest et al. · Journal of Immunotherapy · 2012 · 74 citations

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Robert O. Dillman, Andrew N. Cornforth, Gabriel I. Nistor et al. · Journal for ImmunoTherapy of Cancer · 2018 · 71 citations · Full text

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz et al. · Cancer Biotherapy and Radiopharmaceuticals · 2009 · 67 citations